COLORECTAL CANCER: IT’S TIME TO A CALL FOR ACTION AMONG YOUNG ADULTS

Authors

  • Anca TRIFAN “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Carol STANCIU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Robert NASTASA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ermina STRATINA “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Keywords:

COLORECTAL CANCER, YOUNG ADULTS

Abstract

Currently, colorectal cancer (CRC) is the fourth most prevalent malignancy in both genders in United States of America, with approximately 150,000 new cases identified each year. However, over the past four decades, the overall incidence rate of CRC has considerably decreased (1, 2). Colonoscopy, the primary screening method for CRC, enables the identification and removal of colon polyps before they become malignant. The incidence rates of CRC in persons over 50 years have mostly been attributed to interrupting the adenoma-carcinoma sequence (3). Malignant colorectal malignancies could be found and removed at an early stage, together with the removal of the polyps, to reduce colorectal cancer mortality, by reducing the occurrence of precancerous lesions that would otherwise turn into cancer. In fact, studies using flexible sigmoidoscopy (18-26% in intention-to-screen analyses and 31-35% in per-protocol analyses, in RCTs), colonoscopy (68% in a meta-analysis of observational studies), and fecal immunochemical tests (10-22% in observational studies) have also shown decreased colorectal cancer incidence (4). In contrast, the prevalence of CRC in young patients has been progressively rising every year. In the past ten years, patients with CRC who were diagnosed while they were under 50 years old have formed the young-onset or early-onset CRC patient cohort. The term “young-onset” or “early-onset” colorectal cancer (CRC) refers to CRC that appears in individuals under 50 years who, until recently, did not meet the typical age criteria for average risk screening in the United States (3). This is concerning for a number of reasons. Firstly, this patient group is not routinely examined for colorectal cancer (CRC), as the conventional suggestion is for CRC screening to begin at age 50. Secondly, as we have learned over the past ten years, the concern extends beyond a delay in diagnosis and considers if there are several genetic and environmental factors that distinguish this group of young CRC patients (5).

Author Biographies

  • Anca TRIFAN, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Institute of Gastroenterology and Hepatology
    “Sf. Spiridon” County Clinical Emergency Hospital Iasi

  • Carol STANCIU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    “Sf. Spiridon” County Clinical Emergency Hospital Iasi
    Institute of Gastroenterology and Hepatology

  • Robert NASTASA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    “Sf. Spiridon” County Clinical Emergency Hospital Iasi
    Institute of Gastroenterology and Hepatology

  • Ermina STRATINA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    “Sf. Spiridon” County Clinical Emergency Hospital Iasi
    Institute of Gastroenterology and Hepatology

References

1. Stoffel EM, Murphy CC. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology 2020; 158: 341-353.
2. Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 2015; 150: 17-22.
3. Murphy CC, Lund JL, Sandler RS. Young-Onset Colorectal Cancer: Earlier Diagnoses or Increasing Disease Burden? Gastroenterology 2017; 152: 1809-1812.e3
4. Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol 2021; 22(7):1002-1013.
5. Done JZ, Fang SH. Young-onset colorectal cancer: A review. World J Gastrointest Oncol 2021; 13(8): 856-866.
6. Murphy CC, Singal AG, Baron JA, Sandler RS. Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase. Gastroenterology 2018; 155: 1716-1719.e4.
7. Siegel RL, Fedewa SA, Anderson WF et al. Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst 2017; 109 (8): djw322.
8. Ali Khan U, Fallah M, Sundquist K, Sundquist J, Brenner H, Kharazmi E. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study. PLoS Med 2020; 17: e1003431.
9. Wallace K, DeToma A, Lewin DN, et al. Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older Patients. Clin Colorectal Cancer 2017; 16: 178-186.
10. Holowatyj AN, Ruterbusch JJ, Rozek LS, Cote ML, Stoffel EM. Racial/Ethnic Disparities in Survival Among Patients with Young-Onset Colorectal Cancer. J Clin Oncol 2016; 34: 2148-2156.
11. Chen FW, Sundaram V, Chew TA, Ladabaum U. Low Prevalence of Criteria for Early Screening in Young-Onset Colorectal Cancer. Am J Prev Med 2017; 53: 933-934.
12. Tuohy TM, Rowe KG, Mineau GP, Pimentel R, Burt RW, Samadder NJ. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah. Cancer 2014; 120: 35-42.
13. Siegel RL, Jakubowski CD, Fedewa SA, Davis A, Azad NS. Colorectal Cancer in the Young: Epide-miology, Prevention, Management. Am Soc Clin Oncol Educ Book 2020; 40: 1-14.
14. Ali Khan U, Fallah M, Sundquist K, Sundquist J, Brenner H, Kharazmi E. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study. PLoS Med 2020; 17: e100343.
15. Glover M, Mansoor E, Panhwar M, Parasa S, Cooper GS. Epidemiology of Colorectal Cancer in Average Risk Adults 20-39 Years of Age: A Population-Based National Study. Dig Dis Sci 2019; 64: 3602-3609.
16. Willauer AN, Liu Y, Pereira AAL, et al. Clinical and molecular characterization of early-onset colorectal cancer. Cancer 2019; 125: 2002-2010.
17. Myers EA, Feingold DL, Forde KA, Arnell T, Jang JH, Whelan RL. Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions’ experience. World J Gastroenterol 2013; 19: 5651-5657.
18. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018; 68: 250-281.
19. Săftoiu A, Hassan C, Areia M, et al. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2020; 52(4): 293-304.

Additional Files

Published

2023-12-21